OpenAI's Billion Funding Round: AI Is Now Infrastructure, Not Software
OpenAI just closed a $122 billion funding round at an $852 billion valuation—making it the most valuable private company in history and signaling that...
OpenAI just closed a $122 billion funding round at an $852 billion valuation—making it the most valuable private company in history and signaling that...
Breaking down china's robot revolution: first automated humanoid factory hits 10,000 units per year.
title: "Elon Musk's Terafab: The $25B Chip Factory That Could Reshape AI, EVs, and Space" slug: "elon-musk-terafab-chip-factory-ai-evs-space" excerpt:...
Every startup founder has been there: you spend weeks crafting the perfect product roadmap, only to watch it become irrelevant within months. The mar...
Elon Musk just dropped a hardware bombshell that could reshape the global semiconductor industry. In a Saturday night announcement from Austin, Texas,...
The Pentagon opened GenAI.mil to 3 million personnel with ChatGPT Mil and Grok for Government at IL5 clearance. Anthropic's Claude is the one vendor left out.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.